Article info

Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Free

Authors

  1. Correspondence to Dr Hannah Bower, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm 171 76, Sweden; hannah.bower{at}ki.se
View Full Text

Citation

Bower H, Frisell T, Di Giuseppe D, et al
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

Publication history

  • Received September 6, 2021
  • Accepted October 22, 2021
  • First published November 22, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.